GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Recent study show weight loss injections result in greater weight reduction in women than men, with women losing up to 28% of ...

Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been peer-reviewed. Females in the study were twice as likely to lose hair as males.

People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

Fox News senior medical analyst Dr. Marc Siegel weighs in on President Donald Trump's pharmaceutical executive order aiming to cut drug prices for Americans. Feeling snacky? Everyone knows you can ...